Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Sea 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place To Work
Tech
Tech
Ai
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-suite
Ceo Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
COVID-19 vaccines
COVID-19 vaccines
Page 14 of 95
Tech
Facebook considers relaxing COVID-19 misinformation policies
By
Chris Morris
July 26, 2022
Health
China just approved its first domestic anti-COVID pill, Azvudine, and is ready to produce 6.8 billion pills a year at half the price of Pfizer’s Paxlovid
By
Grady McGregor
July 26, 2022
Health
Pfizer’s anti-COVID pill — used by Biden — is expected to rake in $23.2 billion, but confusion and weak demand could cause supply glut
By
Chloe Taylor
July 25, 2022
Well
The Bill & Melinda Gates Foundation partly funded an Omicron variant study with a surprising conclusion about boosters
By
Christine Mui
July 21, 2022
Health
The U.S.’s woefully low COVID vaccination rate makes it Novavax’s most appealing market yet
By
Grady McGregor
July 20, 2022
Health
CDC endorses Novavax COVID shot for adults, adding to the number of vaccine options
By
Lauran Neergaard
and
The Associated Press
July 19, 2022
Commentary
New viral threats are moving fast. Here’s how we can move faster
By
Gavin Cloherty
July 18, 2022
A ‘breadth of protection’: Novavax’s newly approved COVID vaccine arms the U.S. with a new weapon against Omicron BA.5 subvariant
By
Grady McGregor
July 14, 2022
Commentary
COVID finally got me. Will it come for you?
By
Carolyn Barber
July 12, 2022
Health
An Omicron vaccine is coming. Should you wait for it—or get your next booster now amid BA.5’s surge?
By
Nicholas Gordon
July 12, 2022
Health
New Omicron subvariants are causing COVID rates to increase. These are the states where it’s most contagious right now
By
Andrew Marquardt
July 11, 2022
Commentary
Why remote work will win this fall
By
Gleb Tsipursky
July 11, 2022
Beijing imposes China’s first-ever vaccine mandate as the new, highly transmissible Omicron variant tests its COVID-zero defenses
By
Nicholas Gordon
July 7, 2022
Health
‘We will never be fully vaccinated against COVID’: Canadians may be required to get booster shot every 9 months
By
Sophie Mellor
July 5, 2022
Newsletters
Trust is fundamental to rethinking business’s role in society
By
David Meyer
and
Alan Murray
June 28, 2022
Most Popular
Economy
Ray Dalio says America is developing a ‘dependency’ on the top 1% of workers, while the bottom 60% are struggling and...
By
Eleanor Pringle
Success
Founder of $100 million company says she quit her day job to rebuild her father's Cape Cod chip empire—and there...
By
Emma Burleigh
Politics
Transportation secretary threatens to take $160 million from California over commercial driver’s licenses for...
By
The Associated Press